South Korea seeks tougher penalties against child porn after dark web site bust
South Korea is moving to clarify its definition of child pornography and increase sentences for people convicted of owning such imagery following a global investigation...
Lines but no panic as Lebanese banks re-open after two-week hiatus
Lebanese banks opened on Friday for the first time in two weeks following a wave of protests that prompted the prime minister’s resignation, with lines...
China calls for businesses to shut down e-cigarette online shops
China’s tobacco regulator on Friday issued a notice asking e-commerce platforms and businesses to shut online stores that sell electronic cigarette products, in a move...
Queues but no panic as Lebanese banks re-open after two-week hiatus
Lebanese banks opened on Friday for the first time in two weeks following a wave of protests that prompted the prime minister’s resignation, with queues...
Russia says not enough time left to draft new START arms control treaty: Ifax
Russia’s foreign ministry said on Friday there was no longer enough time left for Moscow and Washington to draft a replacement to the New START...
China to ‘perfect’ Hong Kong leader appointment system, warns on national security
China will “perfect” the way the leader of Hong Kong is appointed and replaced, and won’t tolerate separatism or threats to national security there, a...
Hungary abandons plan for administrative courts, justice minister says
Hungary’s government has abandoned plans to set up separate administrative courts, but it will pass legislation to speed up administrative court cases, Justice Minister Judit...
Lebanese banks re-open for first time in two weeks
Lebanese banks opened to customers on Friday for the first time in two weeks, following a wave of protests that led the prime minister to...
Winter poses new threat to migrants in Bosnian forest camp
Hundreds of migrants from the Middle East and Asia living in a freezing camp in the forests of Bosnia are short of food and bedding...
Novartis arthritis drug fails to prove it is significantly better than rival
A clinical trial of Novartis’s Cosentyx drug has failed to prove it is significantly better than a rival treatment for a type of arthritis, the...